BAYER ASPIRIN EXTRA STRENGTH

BAYER ASPIRIN EXTRA STRENGTH was reported 3979 times

BAYER ASPIRIN EXTRA STRENGTH is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPERKINETIC HEART SYNDROME 8 0.1356
1 GASTROINTESTINAL VASCULAR MALFORMATION HAEMORRHAGIC 9 0.0240
2 BAROTRAUMA 2 0.0217
3 HAEMORRHAGIC ARTERIOVENOUS MALFORMATION 14 0.0150
4 INAPPROPRIATE PRESCRIBING 9 0.0146
5 OESOPHAGITIS HAEMORRHAGIC 4 0.0142
6 ANASTOMOTIC ULCER HAEMORRHAGE 2 0.0140
7 PROSTATIC HAEMORRHAGE 4 0.0125
8 AORTIC VALVE THICKENING 2 0.0124
9 CONTRAINDICATED DRUG PRESCRIBED 3 0.0106
10 BREAST NECROSIS 2 0.0097
11 HAEMORRHAGIC EROSIVE GASTRITIS 3 0.0092
12 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0081
13 CHEST WALL HAEMATOMA 2 0.0078
14 ATRIAL ENLARGEMENT 2 0.0074
15 FOREIGN BODY IN RESPIRATORY TRACT 9 0.0069
16 DREAMY STATE 2 0.0062
17 GASTROENTERITIS BACTERIAL 2 0.0061
18 GASTRIC ULCER HAEMORRHAGE 33 0.0059
19 THALAMUS HAEMORRHAGE 5 0.0057
20 TOBACCO ABUSE 3 0.0056
21 ESSENTIAL HYPERTENSION 10 0.0055
22 DIVERTICULUM INTESTINAL HAEMORRHAGIC 12 0.0053
23 BILE DUCT STENT INSERTION 2 0.0052
24 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 3 0.0051
25 SPINAL EPIDURAL HAEMATOMA 3 0.0051
26 ECHOCARDIOGRAM ABNORMAL 7 0.0050
27 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 44 0.0050
28 BASAL GANGLIA HAEMORRHAGE 4 0.0049
29 LOWER GASTROINTESTINAL HAEMORRHAGE 32 0.0043
30 PEPTIC ULCER HAEMORRHAGE 3 0.0043
31 PERFORATED ULCER 3 0.0040
32 HAEMORRHAGIC DIATHESIS 14 0.0039
33 AKINESIA 8 0.0039
34 DUODENAL ULCER HAEMORRHAGE 11 0.0038
35 UPPER GASTROINTESTINAL HAEMORRHAGE 63 0.0037
36 INCISION SITE HAEMORRHAGE 3 0.0037
37 BLEEDING VARICOSE VEIN 2 0.0037
38 SCIATIC NERVE INJURY 3 0.0036
39 BLOOD LOSS ANAEMIA 8 0.0035
40 SMALL INTESTINAL HAEMORRHAGE 7 0.0035
41 GASTROINTESTINAL POLYP HAEMORRHAGE 2 0.0033
42 HYPERKINESIA 7 0.0033
43 ASPIRIN-EXACERBATED RESPIRATORY DISEASE 2 0.0033
44 ACUTE LEFT VENTRICULAR FAILURE 2 0.0030
45 HAEMORRHAGIC ANAEMIA 13 0.0030
46 GASTRIC HAEMORRHAGE 34 0.0030
47 INTERNAL HAEMORRHAGE 33 0.0029
48 GASTROINTESTINAL HAEMORRHAGE 226 0.0027
49 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 7 0.0027
50 ULCER HAEMORRHAGE 18 0.0027
51 INCORRECT DOSAGE ADMINISTERED 13 0.0027
52 VENTRICULAR HYPOKINESIA 8 0.0025
53 POOR QUALITY DRUG ADMINISTERED 16 0.0025
54 HAEMORRHOIDAL HAEMORRHAGE 12 0.0025
55 INCORRECT DRUG ADMINISTRATION DURATION 67 0.0024
56 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 17 0.0024
57 HAEMORRHAGE URINARY TRACT 6 0.0024
58 SUBCUTANEOUS HAEMATOMA 3 0.0023
59 DEAFNESS TRANSITORY 2 0.0023
60 ADENOCARCINOMA PANCREAS 3 0.0023
61 PRODUCT PACKAGE ASSOCIATED INJURY 5 0.0022
62 NEPHROGENIC ANAEMIA 10 0.0022
63 DRUG DISPENSED TO WRONG PATIENT 2 0.0021
64 HAEMOTHORAX 6 0.0021
65 ABDOMINAL WALL HAEMATOMA 4 0.0020
66 HAEMORRHAGIC STROKE 16 0.0020
67 ANTISOCIAL BEHAVIOUR 2 0.0020
68 HAEMORRHAGIC TRANSFORMATION STROKE 3 0.0020
69 HAEMORRHAGE SUBCUTANEOUS 7 0.0020
70 RENAL HAEMORRHAGE 4 0.0020
71 AXILLARY MASS 2 0.0019
72 AORTIC DILATATION 2 0.0018
73 GASTROINTESTINAL ULCER HAEMORRHAGE 2 0.0018
74 REBOUND ACID HYPERSECRETION 5 0.0017
75 LYMPHADENITIS 4 0.0017
76 WOUND HAEMORRHAGE 6 0.0016
77 RETROPERITONEAL HAEMORRHAGE 4 0.0016
78 INTRAVENTRICULAR HAEMORRHAGE 4 0.0016
79 RECTAL HAEMORRHAGE 68 0.0016
80 GASTRIC ULCER 30 0.0016
81 URINE OUTPUT INCREASED 4 0.0015
82 PRODUCT LABEL ISSUE 10 0.0015
83 CARBON DIOXIDE INCREASED 2 0.0015
84 SUBDURAL HAEMORRHAGE 4 0.0015
85 HAIR DISORDER 12 0.0015
86 JOINT LOCK 4 0.0014
87 BLOOD ELECTROLYTES DECREASED 2 0.0014
88 ANEURYSM 7 0.0014
89 SPUTUM INCREASED 3 0.0014
90 STRESS CARDIOMYOPATHY 8 0.0014
91 PERICARDIAL HAEMORRHAGE 3 0.0014
92 LARGE INTESTINAL HAEMORRHAGE 3 0.0013
93 COAGULATION TIME PROLONGED 2 0.0013
94 EPIGASTRIC DISCOMFORT 5 0.0013
95 PRURITUS GENITAL 3 0.0013
96 HYPERKERATOSIS 7 0.0013
97 PRODUCT PHYSICAL CONSISTENCY ISSUE 7 0.0013
98 INTRA-ABDOMINAL HAEMORRHAGE 3 0.0013
99 INCORRECT DISPOSAL OF PRODUCT 4 0.0012
100 SHOCK HAEMORRHAGIC 10 0.0012
101 RETINAL TEAR 3 0.0012
102 WALKING AID USER 8 0.0012
103 EXPIRED DRUG ADMINISTERED 6 0.0012
104 EXPIRED PRODUCT ADMINISTERED 40 0.0012
105 INCREASED TENDENCY TO BRUISE 11 0.0012
106 PRODUCT PRESCRIBING ISSUE 26 0.0012
107 PLANTAR FASCIITIS 4 0.0012
108 PRODUCT SOLUBILITY ABNORMAL 6 0.0012
109 INCREASED UPPER AIRWAY SECRETION 6 0.0012
110 CERVICAL SPINAL STENOSIS 2 0.0012
111 LIPOMA 3 0.0012
112 LARGE INTESTINE POLYP 8 0.0012
113 RETINAL DISORDER 3 0.0012
114 END STAGE RENAL DISEASE 21 0.0012
115 PRODUCT USE COMPLAINT 18 0.0011
116 RADICULOPATHY 3 0.0011
117 NASAL DISORDER 3 0.0011
118 HAIR COLOUR CHANGES 14 0.0011
119 POST PROCEDURAL HAEMORRHAGE 13 0.0011
120 SHOULDER ARTHROPLASTY 3 0.0011
121 APPARENT DEATH 4 0.0011
122 PRODUCT USE ISSUE 208 0.0011
123 WRONG PATIENT RECEIVED MEDICATION 3 0.0011
124 ACUTE CORONARY SYNDROME 9 0.0011
125 HIATUS HERNIA 14 0.0011
126 PARANASAL SINUS DISCOMFORT 4 0.0011
127 EPISTAXIS 79 0.0011
128 GUN SHOT WOUND 2 0.0011
129 OESOPHAGEAL STENOSIS 3 0.0011
130 DRUG ADMINISTRATION ERROR 32 0.0010
131 PHARYNGEAL DISORDER 3 0.0010
132 BODY HEIGHT DECREASED 11 0.0010
133 LUMBAR SPINAL STENOSIS 3 0.0010
134 PROCEDURAL HAEMORRHAGE 4 0.0010
135 HAEMATURIA 35 0.0010
136 SUSPECTED COUNTERFEIT PRODUCT 4 0.0010
137 ULCER 16 0.0010
138 HAEMORRHAGE INTRACRANIAL 15 0.0010
139 FOREIGN BODY 4 0.0010
140 EAR HAEMORRHAGE 2 0.0010
141 FOREIGN BODY IN THROAT 3 0.0010
142 DRUG EFFECT INCREASED 3 0.0009
143 MADAROSIS 11 0.0009
144 THERAPEUTIC RESPONSE UNEXPECTED 42 0.0009
145 CARDIAC FLUTTER 6 0.0009
146 CHOKING 18 0.0009
147 CHRONIC KIDNEY DISEASE 70 0.0009
148 SUBDURAL HAEMATOMA 13 0.0009
149 DEAFNESS UNILATERAL 5 0.0009
150 PEPTIC ULCER 3 0.0009
151 HIGH DENSITY LIPOPROTEIN DECREASED 3 0.0009
152 HAIR TEXTURE ABNORMAL 12 0.0009
153 INCORRECT PRODUCT ADMINISTRATION DURATION 19 0.0009
154 PRODUCT USE IN UNAPPROVED INDICATION 217 0.0009
155 REGURGITATION 3 0.0009
156 HYPOPNOEA 3 0.0009
157 CAROTID ARTERY STENOSIS 3 0.0009
158 GASTRITIS EROSIVE 4 0.0009
159 SPINAL COLUMN STENOSIS 4 0.0008
160 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
161 BLOOD URINE PRESENT 16 0.0008
162 MACULAR DEGENERATION 10 0.0008
163 HYPERLIPIDAEMIA 10 0.0008
164 HYPOVOLAEMIC SHOCK 4 0.0008
165 DRUG PRESCRIBING ERROR 16 0.0008
166 EYE HAEMORRHAGE 11 0.0008
167 CAROTID ARTERY OCCLUSION 3 0.0008
168 BLINDNESS TRANSIENT 6 0.0008
169 SPRUE-LIKE ENTEROPATHY 4 0.0008
170 NERVE INJURY 9 0.0008
171 SNEEZING 18 0.0008
172 CATHETER SITE HAEMORRHAGE 2 0.0008
173 HAEMORRHAGE 83 0.0008
174 HAEMOPTYSIS 22 0.0008
175 GASTRIC INFECTION 3 0.0008
176 FAECES DISCOLOURED 17 0.0008
177 CANCER PAIN 2 0.0008
178 ANAL INCONTINENCE 7 0.0008
179 PANIC DISORDER 3 0.0008
180 MELAENA 17 0.0008
181 ACTINIC KERATOSIS 2 0.0008
182 PROSTATOMEGALY 3 0.0008
183 SENSITIVITY TO WEATHER CHANGE 4 0.0008
184 PULMONARY CONGESTION 10 0.0008
185 ARTERIOSCLEROSIS CORONARY ARTERY 5 0.0008
186 NEPHROPATHY 7 0.0007
187 INTRACRANIAL ANEURYSM 3 0.0007
188 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
189 MALIGNANT MELANOMA 10 0.0007
190 SQUAMOUS CELL CARCINOMA 7 0.0007
191 COLITIS ISCHAEMIC 5 0.0007
192 CHONDROPATHY 2 0.0007
193 EAR CONGESTION 2 0.0007
194 ABNORMAL LOSS OF WEIGHT 5 0.0007
195 ECCHYMOSIS 5 0.0007
196 COAGULOPATHY 12 0.0007
197 INTENTIONAL PRODUCT MISUSE 63 0.0007
198 DIABETIC COMA 2 0.0007
199 HAEMATEMESIS 18 0.0007
200 CARDIAC FAILURE CHRONIC 3 0.0007
201 HAEMATOLOGICAL MALIGNANCY 2 0.0007
202 RETINAL HAEMORRHAGE 5 0.0007
203 SHOULDER OPERATION 3 0.0007
204 ACUTE KIDNEY INJURY 107 0.0007
205 CEREBRAL HAEMORRHAGE 25 0.0007
206 CORONARY ARTERY BYPASS 4 0.0007
207 PSYCHOLOGICAL TRAUMA 6 0.0007
208 EMPHYSEMA 7 0.0007
209 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
210 DIVERTICULUM INTESTINAL 3 0.0007
211 GROIN PAIN 6 0.0007
212 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 23 0.0007
213 URINE ODOUR ABNORMAL 4 0.0007
214 LIGAMENT RUPTURE 3 0.0007
215 CATARACT OPERATION 4 0.0007
216 SINUS HEADACHE 4 0.0007
217 PRODUCT TASTE ABNORMAL 9 0.0007
218 CEREBROVASCULAR DISORDER 2 0.0007
219 CENTRAL VENOUS CATHETERISATION 2 0.0007
220 DRUG EFFECT DELAYED 3 0.0007
221 RENAL PAIN 7 0.0007
222 IMPAIRED GASTRIC EMPTYING 9 0.0007
223 NOCTURIA 8 0.0007
224 DRUG DISPENSING ERROR 10 0.0007
225 PRESCRIBED UNDERDOSE 13 0.0007
226 NERVE COMPRESSION 6 0.0006
227 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
228 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
229 DIASTOLIC DYSFUNCTION 2 0.0006
230 PIGMENTATION DISORDER 4 0.0006
231 SCOLIOSIS 4 0.0006
232 BACK INJURY 7 0.0006
233 UMBILICAL HERNIA 3 0.0006
234 PRE-EXISTING CONDITION IMPROVED 4 0.0006
235 BLOOD BLISTER 2 0.0006
236 MULTIPLE ALLERGIES 5 0.0006
237 SKIN ABRASION 3 0.0006
238 SPINAL DISORDER 6 0.0006
239 BREAST CANCER RECURRENT 2 0.0006
240 VIRAL UPPER RESPIRATORY TRACT INFECTION 3 0.0006
241 WHITE BLOOD CELL COUNT ABNORMAL 4 0.0006
242 TYPE 2 DIABETES MELLITUS 21 0.0006
243 STENT PLACEMENT 5 0.0006
244 HYPOKINESIA 9 0.0006
245 SOMNAMBULISM 4 0.0006
246 DEAFNESS NEUROSENSORY 2 0.0006
247 SKIN HAEMORRHAGE 9 0.0006
248 DRUG EFFECT INCOMPLETE 22 0.0006
249 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
250 THROAT IRRITATION 27 0.0006
251 BLOOD POTASSIUM DECREASED 18 0.0006
252 HAEMATOCHEZIA 33 0.0006
253 VULVOVAGINAL PRURITUS 3 0.0006
254 TOE AMPUTATION 3 0.0006
255 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 42 0.0006
256 SUBARACHNOID HAEMORRHAGE 6 0.0006
257 VITAMIN D DECREASED 5 0.0006
258 PRODUCT COLOUR ISSUE 3 0.0006
259 PRODUCT CONTAINER ISSUE 5 0.0006
260 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
261 CERVICAL VERTEBRAL FRACTURE 2 0.0006
262 MYOCARDIAL INFARCTION 100 0.0006
263 EXTRASYSTOLES 4 0.0006
264 URINE OUTPUT DECREASED 5 0.0006
265 CONTUSION 55 0.0006
266 DEFAECATION URGENCY 4 0.0006
267 POOR QUALITY PRODUCT ADMINISTERED 6 0.0006
268 SPINAL OSTEOARTHRITIS 5 0.0006
269 EMBOLIC STROKE 2 0.0006
270 SEASONAL ALLERGY 8 0.0006
271 ANORECTAL DISCOMFORT 3 0.0006
272 DIVERTICULUM 4 0.0006
273 CONTRAINDICATED PRODUCT ADMINISTERED 17 0.0006
274 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
275 PRODUCT SIZE ISSUE 3 0.0006
276 BRUXISM 3 0.0006
277 MUSCLE TIGHTNESS 9 0.0006
278 BACK DISORDER 9 0.0006
279 PULMONARY THROMBOSIS 6 0.0005
280 LIMB DISCOMFORT 17 0.0005
281 IRON DEFICIENCY ANAEMIA 5 0.0005
282 CEREBRAL DISORDER 4 0.0005
283 ANGIOPATHY 3 0.0005
284 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
285 PRODUCT PACKAGING ISSUE 5 0.0005
286 MUSCULOSKELETAL DISORDER 10 0.0005
287 GASTRIC DISORDER 18 0.0005
288 KNEE ARTHROPLASTY 11 0.0005
289 GASTROOESOPHAGEAL REFLUX DISEASE 42 0.0005
290 GINGIVAL DISORDER 2 0.0005
291 NICOTINE DEPENDENCE 4 0.0005
292 FAECES HARD 2 0.0005
293 VITAMIN D DEFICIENCY 5 0.0005
294 GINGIVAL BLEEDING 7 0.0005
295 CORONARY ARTERY OCCLUSION 7 0.0005
296 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
297 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
298 ARTERIAL OCCLUSIVE DISEASE 4 0.0005
299 KNEE OPERATION 5 0.0005
300 SINUS DISORDER 10 0.0005
301 ISCHAEMIC STROKE 9 0.0005
302 TRANSIENT ISCHAEMIC ATTACK 17 0.0005
303 BLADDER DISORDER 5 0.0005
304 CARDIAC PACEMAKER INSERTION 3 0.0005
305 GINGIVAL PAIN 4 0.0005
306 HAEMATOMA 13 0.0005
307 GOUT 9 0.0005
308 APHONIA 7 0.0005
309 TINNITUS 23 0.0005
310 CARPAL TUNNEL SYNDROME 7 0.0005
311 BLOOD DISORDER 4 0.0005
312 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 26 0.0005
313 DYSPEPSIA 49 0.0005
314 NERVOUSNESS 26 0.0005
315 FULL BLOOD COUNT DECREASED 10 0.0005
316 FRUSTRATION TOLERANCE DECREASED 4 0.0005
317 INGUINAL HERNIA 3 0.0005
318 APPLICATION SITE DISCOLOURATION 2 0.0005
319 DRY THROAT 5 0.0005
320 MENISCUS INJURY 3 0.0005
321 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
322 SPINAL COMPRESSION FRACTURE 4 0.0005
323 HEMIPLEGIA 4 0.0005
324 LIP SWELLING 16 0.0005
325 RHINORRHOEA 31 0.0005
326 NASAL DRYNESS 3 0.0005
327 CEREBROVASCULAR ACCIDENT 81 0.0005
328 BLOOD UREA INCREASED 8 0.0005
329 MUSCULOSKELETAL PAIN 25 0.0005
330 INFUSION SITE ERYTHEMA 4 0.0005
331 BLOOD CHOLESTEROL INCREASED 22 0.0005
332 BUNDLE BRANCH BLOCK LEFT 2 0.0005
333 SLEEP APNOEA SYNDROME 9 0.0005
334 CATARACT 28 0.0005
335 ABSCESS LIMB 2 0.0005
336 ENTERITIS 3 0.0005
337 GLAUCOMA 9 0.0005
338 DEVICE OPERATIONAL ISSUE 2 0.0005
339 MYOPATHY 4 0.0005
340 EAR PAIN 9 0.0005
341 HYSTERECTOMY 4 0.0005
342 TENDON DISORDER 3 0.0005
343 PAIN IN JAW 13 0.0005
344 KIDNEY INFECTION 9 0.0005
345 FLATULENCE 26 0.0005
346 POLYP 3 0.0005
347 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
348 DYSPHEMIA 2 0.0005
349 PHARYNGEAL OEDEMA 7 0.0005
350 ANKLE FRACTURE 7 0.0005
351 UNDERDOSE 33 0.0005
352 CATHETERISATION CARDIAC 2 0.0005
353 DELUSION 7 0.0005
354 PRODUCT PHYSICAL ISSUE 9 0.0004
355 METASTASES TO LYMPH NODES 3 0.0004
356 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 13 0.0004
357 OROPHARYNGEAL DISCOMFORT 4 0.0004
358 LIMB INJURY 12 0.0004
359 RESTLESS LEGS SYNDROME 8 0.0004
360 SCIATICA 7 0.0004
361 MICTURITION URGENCY 5 0.0004
362 RESPIRATORY ARREST 12 0.0004
363 HAIR GROWTH ABNORMAL 3 0.0004
364 FORMICATION 3 0.0004
365 RENAL FAILURE 57 0.0004
366 FEELING OF DESPAIR 2 0.0004
367 ARTERIOSCLEROSIS 4 0.0004
368 BLOOD IRON DECREASED 5 0.0004
369 CARDIAC TAMPONADE 2 0.0004
370 IRRITABLE BOWEL SYNDROME 9 0.0004
371 ANGINA PECTORIS 12 0.0004
372 SKIN CANCER 9 0.0004
373 ANAPHYLACTIC REACTION 23 0.0004
374 SWOLLEN TONGUE 13 0.0004
375 HERNIA 8 0.0004
376 HEMIPARESIS 7 0.0004
377 FAECES SOFT 3 0.0004
378 MAJOR DEPRESSION 3 0.0004
379 HAEMORRHOIDS 8 0.0004
380 MOUTH HAEMORRHAGE 3 0.0004
381 APPLICATION SITE PAIN 9 0.0004
382 RENAL DISORDER 19 0.0004
383 APPLICATION SITE BURN 2 0.0004
384 ABDOMINAL DISCOMFORT 68 0.0004
385 TENDON RUPTURE 5 0.0004
386 DIABETIC NEUROPATHY 2 0.0004
387 FEELING DRUNK 3 0.0004
388 ABDOMINAL TENDERNESS 2 0.0004
389 COLON CANCER 6 0.0004
390 APPLICATION SITE SWELLING 2 0.0004
391 BRAIN INJURY 4 0.0004
392 CHROMATURIA 9 0.0004
393 PAROSMIA 3 0.0004
394 DRUG TOLERANCE 2 0.0004
395 FEELING COLD 11 0.0004
396 CORONARY ARTERIAL STENT INSERTION 2 0.0004
397 DYSLIPIDAEMIA 2 0.0004
398 FLUID RETENTION 20 0.0004
399 BOWEL MOVEMENT IRREGULARITY 3 0.0004
400 SKIN DISCOLOURATION 18 0.0004
401 DRUG DELIVERY SYSTEM MALFUNCTION 2 0.0004
402 INITIAL INSOMNIA 4 0.0004
403 ROTATOR CUFF SYNDROME 5 0.0004
404 ATRIOVENTRICULAR BLOCK 3 0.0004
405 GASTROENTERITIS VIRAL 7 0.0004
406 CONCUSSION 3 0.0004
407 TOOTHACHE 7 0.0004
408 INCORRECT DOSE ADMINISTERED 88 0.0004
409 FAILURE TO THRIVE 2 0.0004
410 EYE DISCHARGE 4 0.0004
411 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 78 0.0004
412 TENDERNESS 4 0.0004
413 PETECHIAE 4 0.0004
414 CHEST PAIN 71 0.0004
415 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 21 0.0004
416 INCORRECT PRODUCT STORAGE 5 0.0004
417 DRUG SCREEN POSITIVE 3 0.0004
418 IMMUNE SYSTEM DISORDER 5 0.0004
419 SCRATCH 4 0.0004
420 BLOOD GLUCOSE ABNORMAL 7 0.0004
421 FURUNCLE 3 0.0004
422 NASAL DISCOMFORT 3 0.0004
423 JOINT DISLOCATION 4 0.0004
424 RENAL CYST 3 0.0004
425 OSTEOARTHRITIS 16 0.0004
426 BLISTER 21 0.0004
427 FOOD POISONING 2 0.0004
428 SENSORY LOSS 3 0.0004
429 LOCALISED INFECTION 9 0.0004
430 CONSTIPATION 81 0.0004
431 ANAL ABSCESS 2 0.0004
432 MUSCLE DISORDER 3 0.0004
433 RENAL INJURY 11 0.0004
434 THROAT TIGHTNESS 10 0.0004
435 DECUBITUS ULCER 3 0.0004
436 BIPOLAR DISORDER 4 0.0004
437 FEELING JITTERY 7 0.0004
438 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
439 HICCUPS 3 0.0004
440 PULMONARY FIBROSIS 7 0.0004
441 LOWER LIMB FRACTURE 7 0.0004
442 ABDOMINAL PAIN UPPER 75 0.0004
443 PERIPHERAL COLDNESS 5 0.0004
444 ACUTE RESPIRATORY FAILURE 7 0.0004
445 PROSTATIC SPECIFIC ANTIGEN INCREASED 5 0.0004
446 CHOKING SENSATION 2 0.0004
447 PRESCRIBED OVERDOSE 7 0.0004
448 FOOT DEFORMITY 4 0.0004
449 DIVERTICULITIS 10 0.0004
450 ORAL DISCOMFORT 5 0.0004
451 ATRIAL FIBRILLATION 35 0.0004
452 GAIT INABILITY 12 0.0004
453 HEART RATE ABNORMAL 2 0.0004
454 MASS 5 0.0004
455 ORAL PAIN 8 0.0004
456 PRODUCTIVE COUGH 17 0.0004
457 SENSATION OF FOREIGN BODY 3 0.0004
458 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
459 BLOOD PRESSURE ABNORMAL 7 0.0004
460 CARDIAC VALVE DISEASE 2 0.0003
461 PARALYSIS 5 0.0003
462 ANAPHYLACTIC SHOCK 9 0.0003
463 CARDIAC OPERATION 3 0.0003
464 HEAD INJURY 11 0.0003
465 EXERCISE TOLERANCE DECREASED 2 0.0003
466 BLOOD URIC ACID INCREASED 2 0.0003
467 FEEDING DISORDER 7 0.0003
468 HALLUCINATION 26 0.0003
469 DEAFNESS 9 0.0003
470 FLUID OVERLOAD 5 0.0003
471 ARTHRITIS 27 0.0003
472 VISION BLURRED 47 0.0003
473 BURNING SENSATION 24 0.0003
474 BLOOD CALCIUM INCREASED 3 0.0003
475 HIP FRACTURE 11 0.0003
476 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
477 HEAD DISCOMFORT 6 0.0003
478 ENERGY INCREASED 2 0.0003
479 PRODUCT QUALITY ISSUE 46 0.0003
480 CARDIOMYOPATHY 5 0.0003
481 ARRHYTHMIA 16 0.0003
482 WRONG DRUG ADMINISTERED 3 0.0003
483 FALL 112 0.0003
484 CARDIAC FAILURE CONGESTIVE 27 0.0003
485 FACIAL PAIN 3 0.0003
486 IMMUNODEFICIENCY 5 0.0003
487 HYPERTENSION 71 0.0003
488 HAEMARTHROSIS 3 0.0003
489 GASTROINTESTINAL INFECTION 3 0.0003
490 EYE DISORDER 11 0.0003
491 BLOOD GLUCOSE DECREASED 16 0.0003
492 THYROID CANCER 4 0.0003
493 GANGRENE 2 0.0003
494 CARDIAC DISORDER 31 0.0003
495 BURSITIS 4 0.0003
496 GAIT DISTURBANCE 63 0.0003
497 EXOSTOSIS 3 0.0003
498 RETCHING 7 0.0003
499 LOSS OF CONSCIOUSNESS 42 0.0003
500 MEMORY IMPAIRMENT 45 0.0003
501 IMPAIRED WORK ABILITY 7 0.0003
502 BLOOD PRESSURE INCREASED 50 0.0003
503 DRUG DOSE OMISSION 54 0.0003
504 SPINAL OPERATION 4 0.0003
505 THYROID DISORDER 5 0.0003
506 OROPHARYNGEAL PAIN 30 0.0003
507 PRURITUS GENERALISED 7 0.0003
508 PRODUCT DISTRIBUTION ISSUE 3 0.0003
509 THROMBOSIS 26 0.0003
510 MUSCULOSKELETAL CHEST PAIN 5 0.0003
511 AMNESIA 21 0.0003
512 HEPATIC STEATOSIS 6 0.0003
513 NECK PAIN 18 0.0003
514 THINKING ABNORMAL 6 0.0003
515 DEFORMITY 3 0.0003
516 EXTRA DOSE ADMINISTERED 13 0.0003
517 SWELLING 30 0.0003
518 BASAL CELL CARCINOMA 5 0.0003
519 LACERATION 3 0.0003
520 WEIGHT DECREASED 89 0.0003
521 DYSPNOEA EXERTIONAL 12 0.0003
522 FEELING ABNORMAL 76 0.0003
523 PAIN IN EXTREMITY 93 0.0003
524 DRUG EFFECT DECREASED 17 0.0003
525 CARDIOVASCULAR DISORDER 8 0.0003
526 DIABETES MELLITUS 24 0.0003
527 RECALLED PRODUCT ADMINISTERED 3 0.0003
528 HYPERSOMNIA 9 0.0003
529 FOREIGN BODY SENSATION IN EYES 2 0.0003
530 HYPOPHAGIA 8 0.0003
531 MUSCLE SPASMS 57 0.0003
532 INFUSION SITE PAIN 4 0.0003
533 BACK PAIN 72 0.0003
534 OFF LABEL USE 271 0.0003
535 ASTHENIA 116 0.0003
536 APPLICATION SITE VESICLES 2 0.0003
537 DRY MOUTH 25 0.0003
538 DIPLOPIA 8 0.0003
539 MUSCULAR WEAKNESS 35 0.0003
540 DYSPHONIA 18 0.0003
541 ARTHROPATHY 17 0.0003
542 DYSPHAGIA 29 0.0003
543 APPLICATION SITE ERYTHEMA 8 0.0003
544 ACUTE MYOCARDIAL INFARCTION 9 0.0003
545 THERAPY CHANGE 3 0.0003
546 PERIPHERAL SWELLING 47 0.0003
547 NEUROPATHY PERIPHERAL 29 0.0003
548 GASTRITIS 8 0.0003
549 TOOTH INFECTION 4 0.0003
550 LIGAMENT SPRAIN 3 0.0003
551 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
552 DIZZINESS 151 0.0003
553 CHEST DISCOMFORT 31 0.0003
554 SPINAL FRACTURE 6 0.0003
555 LACRIMATION INCREASED 9 0.0003
556 FREQUENT BOWEL MOVEMENTS 8 0.0003
557 TASTE DISORDER 6 0.0003
558 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
559 NEUTROPHIL COUNT INCREASED 3 0.0003
560 INSOMNIA 78 0.0003
561 HEART RATE INCREASED 29 0.0003
562 BLOOD TESTOSTERONE DECREASED 2 0.0003
563 SWELLING FACE 19 0.0003
564 TEMPERATURE INTOLERANCE 3 0.0003
565 HYPOAESTHESIA 43 0.0003
566 COORDINATION ABNORMAL 4 0.0003
567 LOCAL SWELLING 5 0.0003
568 PRODUCT ODOUR ABNORMAL 3 0.0003
569 SPEECH DISORDER 15 0.0003
570 DEMENTIA 8 0.0003
571 DRUG ADMINISTERED AT INAPPROPRIATE SITE 3 0.0003
572 INCONTINENCE 3 0.0003
573 DUODENAL ULCER 2 0.0003
574 ABASIA 7 0.0003
575 EATING DISORDER 6 0.0003
576 DRY EYE 14 0.0003
577 MOVEMENT DISORDER 9 0.0003
578 GALLBLADDER DISORDER 5 0.0003
579 POOR QUALITY SLEEP 6 0.0003
580 COUGH 78 0.0003
581 VAGINAL HAEMORRHAGE 12 0.0003
582 OSTEOMYELITIS 5 0.0003
583 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
584 SKIN LACERATION 3 0.0003
585 LIVER FUNCTION TEST ABNORMAL 8 0.0003
586 OESOPHAGITIS 3 0.0003
587 BONE DISORDER 5 0.0003
588 DYSSTASIA 8 0.0003
589 ASPIRATION 3 0.0003
590 DYSPNOEA 155 0.0003
591 GASTROINTESTINAL PAIN 3 0.0003
592 INJECTION SITE NODULE 3 0.0003
593 BRONCHITIS 20 0.0003
594 URINARY INCONTINENCE 8 0.0003
595 SKIN DISORDER 9 0.0003
596 URINARY RETENTION 9 0.0003
597 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
598 EYE SWELLING 10 0.0003
599 MIDDLE INSOMNIA 5 0.0003
600 OCULAR DISCOMFORT 3 0.0003
601 BLOOD CALCIUM DECREASED 3 0.0003
602 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
603 BLOOD SODIUM DECREASED 5 0.0003
604 JOINT SWELLING 32 0.0003
605 MITRAL VALVE INCOMPETENCE 3 0.0003
606 PALPITATIONS 31 0.0003
607 APPLICATION SITE PRURITUS 6 0.0003
608 BLOOD COUNT ABNORMAL 4 0.0003
609 COLITIS 10 0.0003
610 FOOT FRACTURE 5 0.0003
611 OSTEOPENIA 4 0.0003
612 WEIGHT INCREASED 59 0.0003
613 SCAB 3 0.0003
614 AORTIC ANEURYSM 2 0.0003
615 CHOLECYSTECTOMY 3 0.0003
616 INTENTIONAL PRODUCT USE ISSUE 23 0.0003
617 HIP ARTHROPLASTY 4 0.0003
618 HERPES ZOSTER 15 0.0003
619 FEAR 7 0.0003
620 FOOD ALLERGY 2 0.0003
621 HAEMOLYSIS 2 0.0003
622 RASH PRURITIC 14 0.0003
623 ORAL HERPES 5 0.0003
624 SPLENOMEGALY 3 0.0003
625 ADVERSE DRUG REACTION 23 0.0003
626 BONE PAIN 15 0.0003
627 SPINAL PAIN 3 0.0003
628 SLEEP DISORDER 18 0.0003
629 BALANCE DISORDER 22 0.0003
630 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
631 PROCEDURAL PAIN 7 0.0003
632 BLOOD ALBUMIN DECREASED 2 0.0003
633 HOT FLUSH 19 0.0003
634 PRODUCT PRESCRIBING ERROR 6 0.0003
635 UPPER LIMB FRACTURE 5 0.0003
636 DRUG INEFFECTIVE 330 0.0003
637 ALOPECIA 49 0.0002
638 INTENTIONAL OVERDOSE 16 0.0002
639 DIARRHOEA 161 0.0002
640 NIGHT SWEATS 8 0.0002
641 CRYING 9 0.0002
642 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7 0.0002
643 FIBROMYALGIA 6 0.0002
644 ANAEMIA 47 0.0002
645 URINARY TRACT INFECTION 42 0.0002
646 BLINDNESS 10 0.0002
647 PRODUCT DOSE OMISSION 16 0.0002
648 BODY TEMPERATURE INCREASED 5 0.0002
649 NASOPHARYNGITIS 45 0.0002
650 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
651 ABNORMAL FAECES 2 0.0002
652 CARDIOMEGALY 3 0.0002
653 EYE IRRITATION 14 0.0002
654 RIB FRACTURE 5 0.0002
655 ARTHRALGIA 101 0.0002
656 VISUAL IMPAIRMENT 30 0.0002
657 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
658 PULMONARY HYPERTENSION 5 0.0002
659 EOSINOPHIL COUNT INCREASED 2 0.0002
660 POLLAKIURIA 10 0.0002
661 SECRETION DISCHARGE 3 0.0002
662 PRURITUS 92 0.0002
663 INTENTIONAL DRUG MISUSE 5 0.0002
664 ROAD TRAFFIC ACCIDENT 10 0.0002
665 DERMATITIS ALLERGIC 3 0.0002
666 NASAL CONGESTION 14 0.0002
667 GLYCOSYLATED HAEMOGLOBIN INCREASED 6 0.0002
668 BRAIN OEDEMA 3 0.0002
669 DECREASED APPETITE 55 0.0002
670 WHEEZING 14 0.0002
671 SCAR 4 0.0002
672 SOMNOLENCE 47 0.0002
673 DEPRESSION 53 0.0002
674 ANURIA 2 0.0002
675 HYPOACUSIS 10 0.0002
676 INJECTION SITE INDURATION 3 0.0002
677 DISEASE RECURRENCE 11 0.0002
678 NIGHTMARE 8 0.0002
679 CORONARY ARTERY DISEASE 7 0.0002
680 CARDIAC MURMUR 2 0.0002
681 EYE PAIN 13 0.0002
682 MULTIPLE SCLEROSIS 11 0.0002
683 ASTHMA 26 0.0002
684 FATIGUE 179 0.0002
685 DISCOMFORT 14 0.0002
686 DYSGEUSIA 17 0.0002
687 PARAESTHESIA 36 0.0002
688 HEART RATE DECREASED 8 0.0002
689 DEVICE MALFUNCTION 16 0.0002
690 GRIP STRENGTH DECREASED 2 0.0002
691 BLOOD PRESSURE DECREASED 15 0.0002
692 DEHYDRATION 30 0.0002
693 TOOTH DISORDER 5 0.0002
694 LUNG DISORDER 11 0.0002
695 INFLUENZA 25 0.0002
696 MALAISE 98 0.0002
697 HEADACHE 140 0.0002
698 RASH PAPULAR 5 0.0002
699 SINUS CONGESTION 3 0.0002
700 HEART RATE IRREGULAR 5 0.0002
701 LEUKOCYTOSIS 4 0.0002
702 URTICARIA 37 0.0002
703 ABDOMINAL DISTENSION 23 0.0002
704 MIGRAINE 21 0.0002
705 CYSTITIS 7 0.0002
706 PAIN 135 0.0002
707 PANIC ATTACK 8 0.0002
708 HYPOTHYROIDISM 7 0.0002
709 APPLICATION SITE RASH 3 0.0002
710 ABNORMAL DREAMS 6 0.0002
711 ADVERSE EVENT 20 0.0002
712 TREMOR 36 0.0002
713 PERICARDIAL EFFUSION 5 0.0002
714 STOMATITIS 13 0.0002
715 DIARRHOEA HAEMORRHAGIC 2 0.0002
716 BLOOD TEST ABNORMAL 3 0.0002
717 FLANK PAIN 2 0.0002
718 IMPAIRED HEALING 7 0.0002
719 UNEVALUABLE EVENT 16 0.0002
720 ANXIETY 60 0.0002
721 OCULAR HYPERAEMIA 10 0.0002
722 PROTEINURIA 4 0.0002
723 SYNCOPE 21 0.0002
724 EYE INFLAMMATION 2 0.0002
725 POST PROCEDURAL COMPLICATION 4 0.0002
726 PARAESTHESIA ORAL 3 0.0002
727 SEIZURE 24 0.0002
728 BLOOD GLUCOSE INCREASED 39 0.0002
729 ERUCTATION 4 0.0002
730 DIZZINESS POSTURAL 2 0.0002
731 MYALGIA 35 0.0002
732 PRESYNCOPE 5 0.0002
733 AUTOIMMUNE DISORDER 2 0.0002
734 CEREBRAL INFARCTION 5 0.0002
735 MENORRHAGIA 4 0.0002
736 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
737 RASH 88 0.0002
738 HYPERHIDROSIS 26 0.0002
739 HAEMATOCRIT DECREASED 4 0.0002
740 PULMONARY MASS 3 0.0002
741 TREATMENT NONCOMPLIANCE 11 0.0002
742 AGEUSIA 5 0.0002
743 INJECTION SITE HAEMORRHAGE 16 0.0002
744 BLOOD CREATININE INCREASED 13 0.0002
745 HYPOAESTHESIA ORAL 3 0.0002
746 CONFUSIONAL STATE 32 0.0002
747 PSORIATIC ARTHROPATHY 8 0.0002
748 EYELID PTOSIS 2 0.0002
749 FEELING HOT 12 0.0002
750 OXYGEN SATURATION DECREASED 11 0.0002
751 EAR DISCOMFORT 2 0.0002
752 HAEMOGLOBIN DECREASED 20 0.0002
753 LUNG NEOPLASM MALIGNANT 8 0.0002
754 OSTEOPOROSIS 8 0.0002
755 LYMPHOMA 3 0.0002
756 TENDONITIS 3 0.0002
757 EJECTION FRACTION DECREASED 3 0.0002
758 COGNITIVE DISORDER 9 0.0002
759 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
760 NERVOUS SYSTEM DISORDER 6 0.0002
761 HYPERGLYCAEMIA 7 0.0002
762 RESPIRATORY FAILURE 14 0.0002
763 RHABDOMYOLYSIS 8 0.0002
764 CARDIO-RESPIRATORY ARREST 8 0.0002
765 DERMATITIS 4 0.0002
766 JOINT STIFFNESS 5 0.0002
767 RENAL IMPAIRMENT 16 0.0002
768 GASTROINTESTINAL DISORDER 17 0.0002
769 DRUG INTERACTION 30 0.0002
770 OBESITY 3 0.0002
771 INJECTION SITE BRUISING 15 0.0002
772 EAR INFECTION 5 0.0002
773 BREAST PAIN 2 0.0002
774 JOINT INJURY 4 0.0002
775 NAUSEA 148 0.0002
776 SENSORY DISTURBANCE 3 0.0002
777 DECREASED ACTIVITY 2 0.0002
778 DEEP VEIN THROMBOSIS 12 0.0002
779 PSORIASIS 24 0.0002
780 PRODUCT DISPENSING ERROR 4 0.0002
781 MOOD ALTERED 5 0.0002
782 CHOLELITHIASIS 6 0.0002
783 IRRITABILITY 11 0.0002
784 PLASMA CELL MYELOMA 7 0.0002
785 GLOSSODYNIA 4 0.0002
786 CELLULITIS 9 0.0002
787 EYE PRURITUS 6 0.0002
788 CANDIDA INFECTION 3 0.0002
789 ANGER 6 0.0002
790 EYE INFECTION 2 0.0002
791 AGITATION 13 0.0002
792 INTENTIONAL DOSE OMISSION 5 0.0002
793 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
794 THERAPY CESSATION 9 0.0002
795 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
796 RED BLOOD CELL COUNT DECREASED 5 0.0002
797 NEPHROLITHIASIS 8 0.0002
798 MUSCULOSKELETAL DISCOMFORT 3 0.0002
799 PARANOIA 3 0.0002
800 MUSCLE TWITCHING 4 0.0002
801 PNEUMONIA 56 0.0002
802 RASH MACULAR 6 0.0002
803 OVERDOSE 37 0.0002
804 COLD SWEAT 3 0.0002
805 INJECTION SITE SWELLING 13 0.0002
806 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
807 THIRST 3 0.0002
808 CONDITION AGGRAVATED 51 0.0002
809 ACCIDENT 2 0.0002
810 INJECTION SITE PAIN 51 0.0002
811 SINUSITIS 17 0.0002
812 APHASIA 5 0.0002
813 ILLNESS 17 0.0002
814 NEURALGIA 4 0.0002
815 OEDEMA PERIPHERAL 20 0.0002
816 RESTLESSNESS 6 0.0002
817 VOMITING 77 0.0002
818 INJECTION SITE URTICARIA 4 0.0002
819 EMOTIONAL DISORDER 5 0.0002
820 CHILLS 19 0.0002
821 CONJUNCTIVITIS 3 0.0002
822 CYST 2 0.0002
823 AGGRESSION 8 0.0002
824 PHOTOPHOBIA 3 0.0002
825 DYSARTHRIA 6 0.0002
826 PRODUCT COMPLAINT 4 0.0002
827 DRY SKIN 21 0.0002
828 MOOD SWINGS 5 0.0002
829 METABOLIC ACIDOSIS 5 0.0002
830 DRUG INTOLERANCE 15 0.0002
831 UNRESPONSIVE TO STIMULI 4 0.0002
832 COVID-19 27 0.0002
833 MOBILITY DECREASED 11 0.0002
834 INCORRECT DOSE ADMINISTERED BY DEVICE 4 0.0002
835 STAPHYLOCOCCAL INFECTION 5 0.0002
836 ABNORMAL BEHAVIOUR 6 0.0002
837 DISORIENTATION 6 0.0002
838 PANCREATITIS 8 0.0002
839 DEPRESSED MOOD 8 0.0002
840 HYPERSENSITIVITY 28 0.0002
841 VIRAL INFECTION 5 0.0002
842 FUNGAL INFECTION 5 0.0001
843 RHEUMATOID ARTHRITIS 17 0.0001
844 DRUG DEPENDENCE 24 0.0001
845 PLEURAL EFFUSION 9 0.0001
846 FLUSHING 15 0.0001
847 OEDEMA 8 0.0001
848 PULMONARY EMBOLISM 14 0.0001
849 PALLOR 4 0.0001
850 PRODUCT PREPARATION ERROR 3 0.0001
851 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
852 SKIN LESION 4 0.0001
853 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
854 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
855 TOOTH LOSS 3 0.0001
856 HYPOGLYCAEMIA 7 0.0001
857 WOUND 4 0.0001
858 SKIN EXFOLIATION 12 0.0001
859 DEVICE OCCLUSION 2 0.0001
860 BLINDNESS UNILATERAL 2 0.0001
861 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
862 DIALYSIS 2 0.0001
863 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 10 0.0001
864 HYPOTENSION 28 0.0001
865 LETHARGY 8 0.0001
866 PANCREATIC CARCINOMA 4 0.0001
867 WHITE BLOOD CELL COUNT DECREASED 15 0.0001
868 DEVICE LEAKAGE 6 0.0001
869 MENTAL DISORDER 6 0.0001
870 ABDOMINAL PAIN 32 0.0001
871 DYSURIA 5 0.0001
872 ANGIOEDEMA 6 0.0001
873 LABORATORY TEST ABNORMAL 4 0.0001
874 PSYCHOTIC DISORDER 4 0.0001
875 INJECTION SITE MASS 5 0.0001
876 NEOPLASM MALIGNANT 9 0.0001
877 INFLUENZA LIKE ILLNESS 11 0.0001
878 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 24 0.0001
879 BONE LOSS 2 0.0001
880 SUICIDE ATTEMPT 8 0.0001
881 DEVICE FAILURE 2 0.0001
882 SUICIDAL IDEATION 12 0.0001
883 HOSPITALISATION 20 0.0001
884 DEVICE RELATED INFECTION 2 0.0001
885 PRODUCT DOSE OMISSION ISSUE 38 0.0001
886 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
887 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
888 BONE DENSITY DECREASED 4 0.0001
889 THERAPY INTERRUPTED 9 0.0001
890 DIABETIC KETOACIDOSIS 3 0.0001
891 HEPATIC CANCER 3 0.0001
892 CARDIAC FAILURE 10 0.0001
893 MENTAL IMPAIRMENT 3 0.0001
894 LIVER INJURY 3 0.0001
895 ENCEPHALOPATHY 3 0.0001
896 OSTEONECROSIS 4 0.0001
897 PRODUCT SUBSTITUTION ISSUE 7 0.0001
898 CARDIAC ARREST 10 0.0001
899 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
900 CYTOMEGALOVIRUS INFECTION 2 0.0001
901 PNEUMONIA ASPIRATION 3 0.0001
902 ABDOMINAL PAIN LOWER 3 0.0001
903 ERYTHEMA 24 0.0001
904 NO ADVERSE EVENT 21 0.0001
905 RASH GENERALISED 3 0.0001
906 DEVICE DEFECTIVE 2 0.0001
907 DELIRIUM 4 0.0001
908 ILL-DEFINED DISORDER 7 0.0001
909 VERTIGO 7 0.0001
910 ECZEMA 6 0.0001
911 DEVICE USE ISSUE 2 0.0001
912 HYPERKALAEMIA 4 0.0001
913 HYPOXIA 4 0.0001
914 LIVER DISORDER 5 0.0001
915 PLATELET COUNT DECREASED 12 0.0001
916 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
917 COLITIS ULCERATIVE 5 0.0001
918 ACCIDENTAL OVERDOSE 4 0.0001
919 SKIN IRRITATION 5 0.0001
920 MENTAL STATUS CHANGES 3 0.0001
921 THROMBOCYTOPENIA 12 0.0001
922 BACTERIAL INFECTION 2 0.0001
923 PYREXIA 37 0.0001
924 INTESTINAL OBSTRUCTION 4 0.0001
925 FRACTURE 2 0.0001
926 COMA 5 0.0001
927 INJECTION SITE PRURITUS 7 0.0001
928 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
929 CHOLESTASIS 2 0.0001
930 INFECTION 15 0.0001
931 INTERSTITIAL LUNG DISEASE 5 0.0001
932 MUSCULOSKELETAL STIFFNESS 9 0.0001
933 HEPATIC ENZYME INCREASED 7 0.0001
934 RESPIRATORY DISORDER 3 0.0001
935 INJURY 7 0.0001
936 THERAPEUTIC RESPONSE DECREASED 6 0.0001
937 EPILEPSY 3 0.0001
938 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
939 FEMUR FRACTURE 3 0.0001
940 BREAST CANCER 9 0.0001
941 DEATH 82 0.0001
942 HALLUCINATION, VISUAL 2 0.0001
943 RENAL FAILURE ACUTE 4 0.0001
944 LACTIC ACIDOSIS 3 0.0001
945 VISUAL ACUITY REDUCED 3 0.0001
946 PULMONARY OEDEMA 4 0.0001
947 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
948 DEVICE ISSUE 8 0.0001
949 INJECTION SITE REACTION 6 0.0001
950 SURGERY 5 0.0001
951 RENAL CANCER 4 0.0001
952 PRODUCT ADHESION ISSUE 3 0.0001
953 BLOOD PRESSURE FLUCTUATION 2 0.0001
954 LEUKOPENIA 4 0.0001
955 TACHYCARDIA 7 0.0001
956 ERECTILE DYSFUNCTION 2 0.0001
957 INFLAMMATION 4 0.0001
958 EXPOSURE VIA SKIN CONTACT 2 0.0001
959 BREAST CANCER FEMALE 2 0.0001
960 MEDICATION ERROR 4 0.0001
961 WITHDRAWAL SYNDROME 3 0.0001
962 HYPONATRAEMIA 4 0.0001
963 SKIN BURNING SENSATION 5 0.0001
964 SEPTIC SHOCK 3 0.0001
965 PRODUCT STORAGE ERROR 6 0.0001
966 DRUG WITHDRAWAL SYNDROME 6 0.0001
967 ASCITES 2 0.0001
968 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
969 ACNE 5 0.0001
970 GYNAECOMASTIA 2 0.0001
971 RASH ERYTHEMATOUS 3 0.0001
972 DEVICE DIFFICULT TO USE 4 0.0001
973 TOXICITY TO VARIOUS AGENTS 10 0.0001
974 DISEASE PROGRESSION 7 0.0001
975 BRADYCARDIA 3 0.0001
976 DISTURBANCE IN ATTENTION 3 0.0001
977 CONVULSION 3 0.0001
978 DYSKINESIA 2 0.0000
979 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
980 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
981 INJECTION SITE ERYTHEMA 6 0.0000
982 INFUSION RELATED REACTION 3 0.0000
983 SEPSIS 5 0.0000
984 DRUG DOSE OMISSION BY DEVICE 3 0.0000
985 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
986 PROSTATE CANCER 3 0.0000
987 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
988 EMOTIONAL DISTRESS 4 0.0000
989 NEUTROPENIA 4 0.0000
990 DRUG ABUSE 2 0.0000